Merendino Lauren — SEC Form 4 filings
SEC reporting owner CIK 1855298. 8 Form 4 filings on record with FilingPulse; latest filed 2026-04-23.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-03-28 to 2026-04-23. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 4 legs across 4 filings — 17,233 shares, $150,723 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 44.
- Largest priced transaction: sale of 5,814 shares @ $11.60 ($67,448) in Day One Biopharmaceuticals, Inc., filed 2026-02-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Day One Biopharmaceuticals, Inc. (DAWN) | Chief Commercial Officer | 7 | — | 4 legs · 17,233 sh · $150,723 | 43 |
| ESSA Pharma Inc. (EPIX) | Director | 1 | — | — | 1 |
Form 4 filings — Merendino Lauren
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-04-23 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to issuer (D): 60,157 · Disposition to issuer (D): 330,200 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 90,000 (derivative) · Disposition to issuer (D): 110,000 (derivative) · Disposition to issuer (D): 18,978 (derivative) · +3 more | EDGAR |
| 2026-02-18 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 3,162 · Option exercise (M): 3,688 · Option exercise (M): 3,687 · Option exercise (M): 4,625 · Sale (S): 5,814 @ $11.60 · Option exercise (M): 3,162 (derivative) @ $0 · +3 more | EDGAR |
| 2026-01-30 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Grant/award (A): 110,000 (derivative) @ $0 · Grant/award (A): 74,000 (derivative) @ $0 | EDGAR |
| 2025-11-18 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 3,162 · Option exercise (M): 3,687 · Option exercise (M): 3,687 · Sale (S): 3,726 @ $8.91 · Option exercise (M): 3,162 (derivative) @ $0 · Option exercise (M): 3,687 (derivative) @ $0 · +1 more | EDGAR |
| 2025-11-07 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Disposition to issuer (D): 330,200 (derivative) @ $0 · Grant/award (A): 330,200 (derivative) @ $0 · Disposition to issuer (D): 90,000 (derivative) @ $0 · Grant/award (A): 90,000 (derivative) @ $0 · Disposition to issuer (D): 90,000 (derivative) @ $0 · Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2025-08-19 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 3,162 · Option exercise (M): 3,687 · Option exercise (M): 3,687 · Sale (S): 3,766 @ $6.77 · Option exercise (M): 3,162 (derivative) @ $0 · Option exercise (M): 3,687 (derivative) @ $0 · +1 more | EDGAR |
| 2025-05-19 | 4 | Day One Biopharmaceuticals, Inc. (DAWN) | Option exercise (M): 3,162 · Option exercise (M): 3,687 · Option exercise (M): 3,687 · Sale (S): 3,927 @ $6.26 · Option exercise (M): 3,162 (derivative) @ $0 · Option exercise (M): 3,687 (derivative) @ $0 · +1 more | EDGAR |
| 2024-03-28 | 4 | ESSA Pharma Inc. (EPIX) | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1855298 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →